Letermovir 240 mg in 12 mL Injection
RxNorm 1988652
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1988652 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: letermovir 240 mg in 12 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
12 mL letermovir 20 mg/ML Injection
(Atom ID: 9701976)
SYPrescribable
Synonym (SY):
Letermovir 20 mg/ML per 12 mL Injection
(Atom ID: 9701988)
PSNPrescribable
Prescribable Name (PSN):
Letermovir 240 mg in 12 mL Injection
(Atom ID: 9701990)
SYPrescribable
Synonym (SY):
Letermovir 240 mg per 12 mL Injection
(Atom ID: 9701989)
Patient Education
Letermovir Injection
Letermovir injection is used to help prevent cytomegalovirus (CMV) infection and disease in certain people who have received a hematopoietic stem-cell transplant (HSCT; a procedure that replaces diseased bone marrow with healthy bone marrow) and are at increased risk of developing a CMV infection. Letermovir is in a class of medications called antivirals. It works by slowing the growth of CMV.
[Learn More]
* Please review the disclaimer below.